Several studies showed that cancer cells increase the expression of some checkpoint proteins (summarized in Table 1), such as programmed cell death ligand-1 (PD-L1), with inhibitory properties on T cell functions, as a mechanism of immune resistance (20). Here, CD274 is linked to cancer.